Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-14
DOI
10.3389/fphar.2018.01273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of smooth muscle cells in coronary artery bypass grafting failure
- (2018) Kerry Wadey et al. CARDIOVASCULAR RESEARCH
- ERV1/ChemR23 Signaling Protects from Atherosclerosis by Modifying oxLDL Uptake and Phagocytosis in Macrophages
- (2018) Andres Laguna-Fernandez et al. CIRCULATION
- Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control
- (2018) Asmaa I. Matouk et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration
- (2018) Guizhu Liu et al. FASEB JOURNAL
- Immune responsive resolvin D1 programs myocardial infarction–induced cardiorenal syndrome in heart failure
- (2018) Ganesh V. Halade et al. FASEB JOURNAL
- Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome
- (2018) Aritz Lopategi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats
- (2018) Gang Zuo et al. Molecular Brain
- The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant
- (2017) Yousuf M. Al Suleimani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats
- (2017) Asmaa I. Matouk et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function
- (2017) Amanda J. Kennedy et al. PHARMACOLOGICAL REVIEWS
- Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals
- (2017) Cristina López-Vicario et al. Scientific Reports
- Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function
- (2017) Rima Chattopadhyay et al. Redox Biology
- Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway
- (2017) Giorgio Mottola et al. PLoS One
- ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance
- (2017) Corneliu Sima et al. Scientific Reports
- Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin
- (2016) Kanita Salic et al. ATHEROSCLEROSIS
- Formyl-Peptide Receptor 2/3/Lipoxin A4Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral InflammationCLINICAL PERSPECTIVE
- (2016) Shantel A. Vital et al. CIRCULATION
- Resolvin D2 Enhances Postischemic Revascularization While Resolving InflammationClinical Perspective
- (2016) Michael J. Zhang et al. CIRCULATION
- Novel Resolvin D2 Receptor Axis in Infectious Inflammation
- (2016) Nan Chiang et al. JOURNAL OF IMMUNOLOGY
- Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation
- (2016) Hildur H. Arnardottir et al. JOURNAL OF IMMUNOLOGY
- Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32
- (2016) Mattia Schmid et al. JOURNAL OF IMMUNOLOGY
- Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment
- (2016) Regina M. Krohn et al. Journal of Inflammation-London
- Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses
- (2016) Valerio Chiurchiù et al. Science Translational Medicine
- Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent
- (2015) Sarah K. Orr et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis
- (2015) H. Hasturk et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Adipokine Chemerin Induces Apoptosis in Cardiomyocytes
- (2015) Diego Rodríguez-Penas et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke
- (2015) Helen K. Smith et al. FASEB JOURNAL
- Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice
- (2015) Daisuke Akagi et al. FASEB JOURNAL
- Identification of resolvin D2 receptor mediating resolution of infections and organ protection
- (2015) Nan Chiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regulation of atherosclerotic plaque inflammation
- (2015) M. Bäck et al. JOURNAL OF INTERNAL MEDICINE
- Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function
- (2015) Vasundhara Kain et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Anti-inflammatory therapies for atherosclerosis
- (2015) Magnus Bäck et al. Nature Reviews Cardiology
- Differential regulation of monocytic expression of leukotriene and lipoxin receptors
- (2015) Marcelo Heron Petri et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
- (2015) Gabrielle Fredman et al. Science Translational Medicine
- Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation
- (2015) Mauro Perretti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction
- (2014) Vasundhara Kain et al. BASIC RESEARCH IN CARDIOLOGY
- Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
- (2014) Magnus Bäck et al. BRITISH JOURNAL OF PHARMACOLOGY
- The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
- (2014) Marcelo H. Petri et al. CARDIOVASCULAR RESEARCH
- Resolution of inflammation: targeting GPCRs that interact with lipids and peptides
- (2014) Jenna L. Cash et al. DRUG DISCOVERY TODAY
- GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment
- (2014) Xiaoming Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Chemerin Induces Insulin Resistance in Rat Cardiomyocytes in Part through the ERK1/2 Signaling Pathway
- (2014) Ruining Zhang et al. PHARMACOLOGY
- Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4synthesis by inhibiting a calcium-activated kinase pathway
- (2014) Gabrielle Fredman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation
- (2013) V. Brancaleone et al. BLOOD
- Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation
- (2013) George S Karagiannis et al. BMC Cardiovascular Disorders
- Biomechanical factors in the biology of aortic wall and aortic valve diseases
- (2013) Magnus Bäck et al. CARDIOVASCULAR RESEARCH
- Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents
- (2013) Jesmond Dalli et al. CHEMISTRY & BIOLOGY
- D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury
- (2013) Takuya Miyahara et al. FASEB JOURNAL
- Proresolving and Tissue-Protective Actions of Annexin A1-Based Cleavage-Resistant Peptides Are Mediated by Formyl Peptide Receptor 2/Lipoxin A4 Receptor
- (2013) J. Dalli et al. JOURNAL OF IMMUNOLOGY
- Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma
- (2013) C. Barnig et al. Science Translational Medicine
- Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
- (2012) Sriram Krishnamoorthy et al. AMERICAN JOURNAL OF PATHOLOGY
- N -arachidonoyl glycine induces macrophage apoptosis via GPR18
- (2012) Rina Takenouchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lack of Neutrophil-Derived CRAMP Reduces Atherosclerosis in Mice
- (2012) Yvonne Döring et al. CIRCULATION RESEARCH
- Resolvin E1 and Chemokine-like Receptor 1 Mediate Bone Preservation
- (2012) L. Gao et al. JOURNAL OF IMMUNOLOGY
- Infection regulates pro-resolving mediators that lower antibiotic requirements
- (2012) Nan Chiang et al. NATURE
- The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques
- (2012) Janine M van Gils et al. NATURE IMMUNOLOGY
- Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation
- (2012) D. El Kebir et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation
- (2012) Antonio Recchiuti et al. Frontiers in Immunology
- Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases
- (2011) Hideyuki Umeda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells
- (2011) Douglas McHugh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chemical Mediators of Inflammation and Resolution in Post-Operative Abdominal Aortic Aneurysm Patients
- (2011) Padmini S. Pillai et al. INFLAMMATION
- Aspirin-Triggered Lipoxin and Resolvin E1 Modulate Vascular Smooth Muscle Phenotype and Correlate with Peripheral Atherosclerosis
- (2010) Karen J. Ho et al. AMERICAN JOURNAL OF PATHOLOGY
- Resolvin E1 protects the rat heart against reperfusion injury
- (2010) K. T. Keyes et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
- (2010) Douglas McHugh et al. BMC NEUROSCIENCE
- Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans
- (2010) J.-B. Michel et al. CARDIOVASCULAR RESEARCH
- Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3
- (2010) T. Kiwamoto et al. CLINICAL AND EXPERIMENTAL ALLERGY
- FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
- (2010) Paola Maderna et al. FASEB JOURNAL
- MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits
- (2010) Antonio Recchiuti et al. FASEB JOURNAL
- Resolvin D1 binds human phagocytes with evidence for proresolving receptors
- (2010) S. Krishnamoorthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mediators of neutrophil recruitment in human abdominal aortic aneurysms
- (2009) Xavier Houard et al. CARDIOVASCULAR RESEARCH
- Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus
- (2009) Xavier Houard et al. FASEB JOURNAL
- Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis
- (2009) Taisuke Ohira et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
- (2009) R. D. Ye et al. PHARMACOLOGICAL REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started